Helius Medical Approves 1-for-50 Reverse Stock Split Effective July 1, 2025
I'm PortAI, I can summarize articles.
Helius Medical Technologies Inc. has approved a 1-for-50 reverse stock split of its Class A common stock, effective July 1, 2025. This decision, made by the Board of Directors, aims to meet Nasdaq’s listing requirements. The stock will continue to trade under the symbol "HSDT" with a new CUSIP number.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments